Allscripts Healthcare Solutions - MDRX Stock Forecast, Price & News

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 1 sell rating, 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MDRX shares.
View MDRX analyst ratings or view top-rated stocks.

6 equities research analysts have issued 1 year price objectives for Allscripts Healthcare Solutions' stock. Their MDRX share price forecasts range from $17.00 to $26.00. On average, they expect the company's share price to reach $22.00 in the next year. This suggests a possible upside of 18.6% from the stock's current price.
View analysts price targets for MDRX or view top-rated stocks among Wall Street analysts.

Allscripts Healthcare Solutions' stock was trading at $18.45 at the beginning of the year. Since then, MDRX stock has increased by 0.5% and is now trading at $18.55.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our MDRX earnings forecast.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) issued its earnings results on Thursday, November, 3rd. The software maker reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.04. The software maker earned $151.90 million during the quarter, compared to analyst estimates of $152.79 million. Allscripts Healthcare Solutions had a trailing twelve-month return on equity of 10.74% and a net margin of 7.25%. Allscripts Healthcare Solutions's revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.21 EPS.

Allscripts Healthcare Solutions declared that its Board of Directors has initiated a stock repurchase program on Wednesday, May 26th 2021, which authorizes the company to repurchase $350,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 14% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's board believes its stock is undervalued.

796 employees have rated Allscripts Healthcare Solutions Chief Executive Officer Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Allscripts Healthcare Solutions' stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (19.06%), Vanguard Group Inc. (12.40%), Dimensional Fund Advisors LP (8.36%), Fisher Asset Management LLC (4.86%), State Street Corp (3.80%) and Jacobs Levy Equity Management Inc. (1.46%). Insiders that own company stock include Brian Farley, Dennis Olis, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Leah Jones, Lisa Khorey, Michael Klayko, Paul Black, Richard J Poulton and Thomas Langan.
View institutional ownership trends.

Shares of MDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MDRX stock can currently be purchased for approximately $18.55.

Allscripts Healthcare Solutions (NASDAQ:MDRX) has a market capitalization of $2.03 billion and generates $1.50 billion in revenue each year. The software maker earns $134.44 million in net income (profit) each year or $0.43 on an earnings per share basis.

The company employs 8,000 workers across the globe.

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The official website for the company is www.allscripts.com. The software maker can be reached via phone at (800) 334-8534, via email at stephen.shulstein@allscripts.com, or via fax at 313-322-9600.